Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL)

Author: Sirohi Bhawna   Cunningham David   Norman Andy   Last Kim   Chau Ian   Horwich Alan   Oates Jacqui   Chong Geoffrey   Wotherspoon Andrew  

Publisher: Maney Publishing

ISSN: 1024-5332

Source: Hematology, Vol.12, Iss.2, 2007-04, pp. : 149-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content